DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Diepstraten J, Janssen EJ, Hackeng CM. , et al.
Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.
Eur J Clin Pharmacol 2015;
71 (01) 25-34
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.